TGFB1 and neoplasm: Furthermore, anti–TGF-β1 monoclonal antibody treatment blocked IL-6 secretion by BMSCs and also inhibited the increments in IL-6 secretion by BMSCs induced by MM cell adhesion (Urashima et al., 1996), suggesting the role of TGF-β1 in tumor cell proliferation.